|
0
|
|
Enhancing tumor T cell antigen prediction by integrating deep protein representations.
(link.springer.com)
|
Oskay U
…
Sefer E
BMC Bioinformatics
2026-07-10
|
#immunotherapy
#cancer
#prediction
#machine learning
#proteomics
|
|
0
|
|
Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells.
(science.org)
|
Cepika AM
…
Roncarolo MG
Science Advances
2026-07-10
|
#transcriptomics
#immunology
#epigenetics
#differentiation
#immunotherapy
|
|
0
|
|
Polyvinyl chloride promotes radioresistance in hepatocellular carcinoma by inhibiting radiotherapy-induced CD8(+) T cell differentiation.
(nature.com)
|
Zhang H
…
Sheng H
Nature Communications
2026-07-10
|
#radiotherapy
#hepatocellular carcinoma
#immunotherapy
#cholesterol metabolism
#t cell differentiation
|
|
0
|
|
Engineering trispecific IL-2 receptor agonistic antibodies through geometry optimization for enhanced Treg targeting.
(nature.com)
|
Lykhopiy V
…
Schlenner SM
Nature Communications
2026-07-10
|
#immunotherapy
#antibody
#autoimmunity
#immunoengineering
#tolerance
|
|
0
|
|
Another complement inhibitor therapy for myasthenia gravis: Is it NIMBLE enough?
(linkinghub.elsevier.com)
|
Kusner LL
…
Kaminski HJ
Cell Med
2026-07-10
|
#myasthenia gravis
#complement
#immunotherapy
#rnai
|
|
0
|
|
Colorectal cancer landscape from gut microbiota: Insights into mutations, epigenetic dysregulation, and immune microenvironment alterations.
(tandfonline.com)
|
Li Y
…
Wen J
Virulence
2026-07-10
|
#microbiome
#colorectal cancer
#dysbiosis
#epigenetics
#immunotherapy
|
|
0
|
|
FDA-approved fulvestrant-induced CAR phase separation enables precise control of CAR T antitumor function.
(linkinghub.elsevier.com)
|
Huang Y
…
Wang H
Cell Stem Cell
2026-07-10
|
#car-t
#immunotherapy
#cancer
#phase separation
#protein design
|
|
0
|
|
Antibody-drug conjugates and the need for third-modality regulatory science.
(linkinghub.elsevier.com)
|
Jiang N
…
Li N
Cell Med
2026-07-10
|
#immunotherapy
#regulation
#pharmacology
#manufacturing
#oncology
|
|
0
|
|
Oncogenic EGFR rewires STING-TBK1 signalosomes to license DNA damage tolerance in NSCLC.
(link.springer.com)
|
Shen Q
…
Xu P
The EMBO Journal
2026-07-10
|
#nsclc
#chemoresistance
#signaling
#dna repair
#immunotherapy
|
|
0
|
|
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.
(nature.com)
|
Lim M
…
Grossman SA
Nature Medicine
2026-07-10
|
#immunotherapy
#glioblastoma
#checkpoint
#t cell
#oncology
|
|
0
|
|
HBsAg seroreversion after pegylated interferon alpha induced HBsAg seroclearance in patients with chronic hepatitis B: a real-world cohort study.
(link.springer.com)
|
Zhang W
…
Song J
BMC Infectious Diseases
2026-07-10
|
#hepatitis
#immunotherapy
#seroreversion
#prognosis
#antiviral
|
|
0
|
|
Prediction of microvascular invasion in hepatocellular carcinoma using contrast-enhanced ultrasound and deep learning.
(nature.com)
|
Pang C
…
Liang P
Nature Communications
2026-07-10
|
#hepatocellular carcinoma
#deep learning
#imaging
#prognosis
#immunotherapy
|